Investigating prognostic features in high-grade serous ovarian cancer through gene regulatory network inference with...

This study aimed to identify prognostic features in high-grade serous ovarian cancer (HGSOC) through the application of gene regulatory network (GRN) inference with single-cell RNA-sequencing (scRNA-seq) profiles. To achieve this goal, we developed a workflow comprising scRNA-seq analysis, metacell construction, GRN inference, and a binary classification task for prognosis prediction. We curated 118,173 cells from HGSOC patients in three conditions (Before-chemotherapy, After-chemotherapy, and control samples) from previous studies, and then constructed 1,211 metacells. GRN inference analysis revealed 312 regulons, each consisting of one transcription factor and its targeted features. For prognosis evaluation, we used bulk RNA-seq data covering 342 HGSOC patients from The Cancer Genome Atlas (TCGA) and defined a binary outcome of overall survival ≥ 2 years from initial diagnosis, with censored cases at last follow-up assigned to the appropriate class by observed time. We prioritized the features of the TCGA data based on regulon information and differentially expressed features extracted from the metacell data. Our results demonstrated that regulon-based prognostic features were more effective than differential expression-based features in both Before-chemotherapy and After-chemotherapy groups. Our framework can be generalized to other types of cancer when single-cell data for GRN inference and bulk RNA-seq data with clinical outcomes are available.